Further studies are needed to evaluate whether AhR signaling can maintain attenuated TRAIL activity and tumor progression after PH even if TRAIL activity and cytotoxicity of lr‐NK cells are reduced in NAFLD and NASH models. Here, AHR is linked to metabolic dysfunction-associated steatotic liver disease.